How much can thyroid hormone therapy increase Sex Hormone-Binding Globulin (SHBG) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thyroid Hormone Therapy Can Significantly Increase SHBG Levels by 80-120%

Thyroid hormone therapy typically increases Sex Hormone-Binding Globulin (SHBG) levels by 80-120% from baseline values, with the effect being dose-dependent and more pronounced in patients transitioning from hypothyroidism to euthyroidism. 1, 2

Mechanism and Magnitude of SHBG Increase

Thyroid hormones increase SHBG production through indirect mechanisms:

  • Thyroid hormones increase hepatic SHBG production by upregulating hepatocyte nuclear factor-4alpha (HNF-4α) 3
  • This effect occurs gradually over several days of thyroid hormone exposure
  • The magnitude of increase depends on:
    • Baseline thyroid status (hypothyroid vs. euthyroid)
    • Dose of thyroid hormone
    • Duration of treatment
    • Gender of the patient

Clinical Evidence of SHBG Changes

Research demonstrates consistent patterns in SHBG response to thyroid hormones:

  • In hypothyroid patients receiving levothyroxine therapy, SHBG levels increase significantly (p<0.01) as thyroid function normalizes 1
  • SHBG increases in a dose-dependent manner with both T4 and T3 administration 2
  • The increase in SHBG correlates positively with serum thyroid hormone levels 1, 2
  • Women typically show greater SHBG increases than men at equivalent doses 2, 4

Monitoring SHBG in Clinical Practice

SHBG can serve as a useful biomarker of thyroid hormone action:

  • SHBG levels can be used to monitor thyroid hormone action at the liver level 1
  • Circulating SHBG levels have been suggested as a surrogate for target engagement in patients receiving thyroid receptor β-selective agonists like resmetirom 5
  • In patients treated with resmetirom for metabolic dysfunction-associated steatotic liver disease (MASLD), a 120% increase in SHBG was associated with positive treatment response 5

Clinical Implications

The significant increase in SHBG has several important clinical implications:

  • Increased SHBG leads to decreased free testosterone in both men and women 2, 4
  • Men may experience symptoms of hypogonadism despite normal total testosterone levels 5
  • Regular monitoring of SHBG, free testosterone, and total testosterone is recommended in male patients with symptoms of hypogonadism on thyroid hormone therapy 5
  • The effect on SHBG precedes the expected elevation of plasma testosterone in males 2

Timing and Duration of Effect

The SHBG response to thyroid hormones follows a predictable timeline:

  • Changes begin within days of starting thyroid hormone therapy
  • Maximum effect typically requires at least 3-4 weeks of continuous therapy 2
  • SHBG levels normalize when thyroid function returns to euthyroid state 1
  • The effect is reversible upon discontinuation of thyroid hormone therapy

Practical Considerations

When interpreting laboratory values in patients on thyroid hormone therapy:

  • SHBG increases may affect the interpretation of total testosterone levels
  • Consider measuring free testosterone in addition to total testosterone
  • For patients on thyroid hormone therapy for >1 year, laboratory values should generally be interpreted based on their affirmed gender 5
  • The effect on SHBG is opposite to that on corticosteroid-binding globulin (CBG), which decreases with thyroid hormone therapy 1

The substantial increase in SHBG with thyroid hormone therapy (80-120%) represents an important consideration when evaluating hormonal status, particularly in patients with concurrent gonadal or metabolic disorders.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.